Log rank | Multivariate | |||||
---|---|---|---|---|---|---|
Variable | X2 | DF | P | Hazard risk | 95% CI | P |
CIN III + invasive CA (n=106) | ||||||
"Total TK1" | 8.60 | 1 | 0.003 | 3.30 | 1.3 – 8.8 | 0.015 |
"Cyto+nucl TK1" | 11.39 | 1 | <0.001 | 4.30 | 1.7 – 10.9 | 0.002 |
Ki-67 | 4.13 | 1 | 0.042 | nd | nd | 0.541 |
Pathological stages: | ||||||
0 versus II | 12.51 | 1 | <0.001 | 6.53 | 1.35-31.38 | 0.020 |
0 versus III | 7.315 | 1 | 0,007 | nd | nd | 0.065 |
FIGO stages: | ||||||
0 versus IA-IIA | 13.23 | 1 | <0.001 | 9.19 | 1.68-50.35 | 0.011 |
0 versus IIB-IV | 9.47 | 1 | 0.002 | nd | nd | 0.060 |
Age | 0.25 | 1 | 0.873 | nd | nd | 0.160 |
Invasive CA (n=61) | ||||||
"Total TK1" | 3.51 | 1 | 0,061 | nd | nd | 0.060 |
"Cyto+nucl TK1" | 6.59 | 1 | 0,01 | 7.19 | 1.7– 29.7 | 0.015 |
Ki-67 | 0.00 | 1 | 0.999 | nd | nd | 0.468 |
FIGO stages IA+IIA versus IIB+IV | 0.44 | 1 | 0.509 | nd | nd | 0.889 |
Pathological stage II versus III | 0.91 | 1 | 0.329 | nd | nd | 0.280 |
Age | 2.27 | 1 | 0.132 | nd | nd | 0.180 |